Gladius Pharmaceuticals
Latest round
- Series A
Last raised
- Jun 2015
Total raised
- $3.4M
Investors
- 3
About Gladius Pharmaceuticals
Founded in 2015 and based in Montreal, Canada, Gladius Pharmaceuticals Corp. is a biotechnology company that develops therapeutics to treat life-threatening infections.
Who invested in Gladius Pharmaceuticals
3 investors across 1 round
See all investors in Gladius Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 22, 2015
Amount
$3.4M
Investors
Questions about Gladius Pharmaceuticals
Who invested in Gladius Pharmaceuticals?
Gladius Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gladius Pharmaceuticals raised?
Gladius Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gladius Pharmaceuticals last raise money?
Gladius Pharmaceuticals's most recent round on record is a Series A, in Jun 2015.
What does Gladius Pharmaceuticals do?
Founded in 2015 and based in Montreal, Canada, Gladius Pharmaceuticals Corp.
Where is Gladius Pharmaceuticals headquartered?
Gladius Pharmaceuticals is headquartered in Montreal, Canada.
Which VCs invest in companies like Gladius Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Gladius Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Gladius Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.